Jim Pankow, PhD, MPH

I am an epidemiologist whose long-term research goal is to identify and characterize risk factors for cardiovascular disease, type 2 diabetes, and other chronic conditions of aging. During my career I have helped assemble large genetic epidemiologic cohorts of cardiovascular disease, investigated genetic determinants of proteins involved in inflammation, hemostasis, and cellular adhesion, researched novel risk factors for type 2 diabetes, including genetic and epigenetic determinants, and evaluated new methods and approaches in statistical genetics in collaboration with faculty in biostatistics.

• American Heart Association Council on Epidemiology and Prevention
• Society for Epidemiologic Reseach

• 2016–2020, "Epigenetics of Successful Aging," Principal Investigator
• 2016–2020, "Diabetes and Prediabetes in Older Adults in ARIC," Principal Investigator
• 2014–2019, "Familial and Birth Cohort Effects on the Aging Senses," Principal Investigator
• 2013–2017, "Genetic Epidemiology of Causal Variants Across the Life Course Phase II," Principal Investigator
• 2017–2020, "Epidemiology of Venous Thrombosis and Pulmonary Embolism (LITE)," Co-Investigator
• 2016–2022, NIH NHLBI, "Atherosclerosis Risk in Communities (ARIC) Study," Co-Investigator
• 2015–2020, "Multi-Ethnic Study of Atherosclerosis (MESA)," Co-Investigator
• 2014–2019, NIH NHLBI, "Cardiovascular Disease Epidemiology and Prevention," Co-Investigator

See a full list of publications on PubMed